NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
NASDAQ: NAMS · HEALTHCARE · BIOTECHNOLOGY
$28.43
-1.01% today
Updated 2026-04-29
Market cap
$3.27B
P/E ratio
—
P/S ratio
145.26x
EPS (TTM)
$-1.72
Dividend yield
—
52W range
$17 – $42
Volume
0.9M
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-206,188.00%
ROE
-28.30%
ROA
-17.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $0.00 | $-7.02M | — | — | — |
| 2021 | $0.00 | $-41.78M | — | — | — |
| 2022 | $102.69M | $-22.63M | 100.00% | -3.46% | -22.04% |
| 2023 | $14.09M | $-176.94M | 100.00% | -1,298.56% | -1,255.76% |
| 2024 | $45.56M | $-241.60M | 100.00% | -386.91% | -530.25% |
| 2025 | $22.50M | $-203.82M | 99.74% | -1,002.90% | -905.74% |